Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lee's Pharmaceutical Holdings Limited (HK:0950)
:0950
Holding HK:0950?
Track your performance easily
0950 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.00 - HK$1.60
Previous CloseN/A
Volume7.00K
Average Volume (3M)106.73K
Market Cap
HK$736.04M
Enterprise ValueHK$678.65M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)11.7
Beta0.46
Next Earnings
Mar 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 12, 2024Dividend Yield2.4%
Share Statistics
EPS (TTM)0.11
Shares Outstanding588,835,300
10 Day Avg. Volume74,700
30 Day Avg. Volume106,733
Standard Deviation0.12
R-Squared0.16
Alpha-0.00831
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.68
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lee's Pharmaceutical Holdings Limited News
PremiumCompany Announcements
Lee’s Pharmaceutical Announces Land Resumption Agreement
PremiumCompany Announcements
Lee’s Pharm Advances with New Drug Application
PremiumCompany Announcements
Lee’s Pharmaceutical Announces Interim Dividend
PremiumCompany Announcements
Lee’s Pharmaceutical Posts Strong Mid-Year Growth
PremiumCompany Announcements
Lee’s Pharmaceutical Board to Review Mid-Year Results
PremiumCompany Announcements
Lee’s Pharmaceutical Expects Major Profit SurgeOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.45% Mutual Funds
― Other Institutional Investors
99.55% Public Companies and
Individual Investors
0950 FAQ
What was Lee's Pharmaceutical Holdings Limited’s price range in the past 12 months?
Lee's Pharmaceutical Holdings Limited lowest stock price was HK$1.00 and its highest was HK$1.60 in the past 12 months.
What is Lee's Pharmaceutical Holdings Limited’s market cap?
Lee's Pharmaceutical Holdings Limited’s market cap is HK$736.04M.
When is Lee's Pharmaceutical Holdings Limited’s upcoming earnings report date?
Lee's Pharmaceutical Holdings Limited’s upcoming earnings report date is Mar 27, 2025 which is in 65 days.
How were Lee's Pharmaceutical Holdings Limited’s earnings last quarter?
Lee's Pharmaceutical Holdings Limited released its earnings results on Aug 28, 2024. The company reported HK$0.106 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.106.
Is Lee's Pharmaceutical Holdings Limited overvalued?
According to Wall Street analysts Lee's Pharmaceutical Holdings Limited’s price is currently Overvalued.
Does Lee's Pharmaceutical Holdings Limited pay dividends?
Lee's Pharmaceutical Holdings Limited pays a Annually dividend of HK$0.028 which represents an annual dividend yield of 2.4%. See more information on Lee's Pharmaceutical Holdings Limited dividends here
What is Lee's Pharmaceutical Holdings Limited’s EPS estimate?
Lee's Pharmaceutical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lee's Pharmaceutical Holdings Limited have?
Lee's Pharmaceutical Holdings Limited has 588,835,300 shares outstanding.
What happened to Lee's Pharmaceutical Holdings Limited’s price movement after its last earnings report?
Lee's Pharmaceutical Holdings Limited reported an EPS of HK$0.106 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lee's Pharmaceutical Holdings Limited?
Currently, no hedge funds are holding shares in HK:0950
---
Lee's Pharmaceutical Holdings Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.79%
12-Months-Change
Fundamentals
Return on Equity
3.42%
Trailing 12-Months
Asset Growth
-12.04%
Trailing 12-Months
Company Description
Lee's Pharmaceutical Holdings Limited
Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology and obstetrics. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase and Eyprotor. Its Licensed-in Products include Carnitene, Ferplex, ALOXI and Centraxal Plus, among others.
---
Technical Analysis
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
―
China Tonghai International Financial Limited
―
---